Navigation Links
Calixa Therapeutics Announces Initiation of Phase 2 Clinical Trial of Its Antibiotic, CXA-101, in Patients with Complicated Urinary Tract Infections
Date:6/30/2009

resistance, we are working diligently to expedite the development of CXA-101. We are fully committed to providing patients and physicians with a much needed option for the treatment of life-threatening infections caused by gram-negative bacteria."

About Calixa Therapeutics

Calixa Therapeutics Inc. is a biopharmaceutical company committed to the development and commercialization of novel medicines for the treatment of infectious diseases. The company's initial focus is on developing novel antibiotics for use in the hospital setting. Calixa Therapeutics, which is privately held, is headquartered in San Diego and has operations in the San Francisco Bay Area. For additional information, please visit: www.calixainc.com.

    Contacts:
    Robert Flamm, Ph.D., or David Schull
    Russo Partners
    (212) 845-4226
    robert.flamm@russopartnersllc.com
    david.schull@russopartnersllc.com

    Eckard Weber, M.D.
    Calixa Therapeutics Inc.
    (858) 480-2420
    stone@domainvc.com

'/>"/>
SOURCE Calixa Therapeutics Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Calixa Therapeutics Announces Positive Phase 1 Results for CXA-101, a Novel Intravenous Cephalosporin Antibiotic with Excellent Anti-Pseudomonal Activity
2. Vantia Therapeutics Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia
3. Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal(TM) for the Treatment of Fabry Disease
4. Horizon Therapeutics HZT-501 Significantly Reduces Incidence of NSAID-Induced Upper Gastrointestinal Ulcers in Patients With Mild-to-Moderate Pain
5. InteKrin Therapeutics to Present at the 2009 American Diabetes Association Annual Meeting
6. Fate Therapeutics Announces First Patient Treated in Phase 1b Clinical Trial of FT1050 for Hematopoietic Stem Cell Support
7. Ascenta Therapeutics Announces Multiple Presentations on AT-101 at 2009 ASCO Annual Meeting
8. Oxford BioTherapeutics and GlaxoSmithKline Form Strategic Alliance to Develop Novel Cancer Therapeutic Antibodies
9. FDA Accepts Arno Therapeutics IND for AR-12 a PDK1 Inhibitor That Blocks the PI3K/Akt Pathway
10. Logical Therapeutics Appoints Peter A. Lankau as CEO and Director
11. Arcion Therapeutics Topical Pain Candidate, ARC-4558, Significantly Reduces Pain Caused by Diabetic Neuropathy

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009).... 6 With his proposed health care ...ghts on cutting name-brand prescription drug costs... the "Part D" coverage gap, universally known as t...ential cost-cutting and feel it,s a promising star...rful lobbyists want a revised program that complet...
(Date:11/6/2009)... N.C., Nov. 6 Chimerix, Inc., a bi... antiviral therapeutics to address life-threatenin...f the company,s lead antiviral compound, CMX001, t...al Health Security Initiative (GHSI). CMX001 is a...r the treatment of smallpox, as well as other seri...
(Date:11/6/2009)...wswire/ -- NexBio Inc., in collaboration with scie...ention (CDC), St. Louis University, and the Univer... of two articles in the peer-reviewed journal PLoS...S181 (Fludase ® ) may play a potentially impo... Pandemic Influenza A(H1N1) and drug-resistant inf...
Breaking Medicine Technology:Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 2Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the 'Donut Hole' 3Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 2NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 3NexBio(R) Publishes Two Articles Showing DAS181 (Fludase(R)*) Potently Inhibits Pandemic Influenza A(H1N1) and NAI-Resistant Influenza Viruses 4Assisted Living Food Service Managers Learn About Food Recall Procedures 57639 1Assisted Living Food Service Managers Learn About Food Recall Procedures 57639 2Assisted Living Food Service Managers Learn About Food Recall Procedures 57639 3Refurbished Medical Imaging Equipment Provider Receives Prestigious Industry Honor 57635 1Refurbished Medical Imaging Equipment Provider Receives Prestigious Industry Honor 57635 2Jennerex Completes Over Subscribed Series C Financing for Aggregate Gross Proceeds of Over 245 5 Million 14142 1Jennerex Completes Over Subscribed Series C Financing for Aggregate Gross Proceeds of Over 245 5 Million 14142 2Jennerex Completes Over Subscribed Series C Financing for Aggregate Gross Proceeds of Over 245 5 Million 14142 3
...08 Thermo Fisher,Scientific Inc. (NYSE: TMO ), t... it has received U.S. Food and Drug Administration...gned to screen for methicillin-resistant,Staphyloc...uperbug." With,the highest Positive Predictive Val...tra provides accurate results within 24 hours. The...
...m results from phase 2 trial of novel compound ...Conn., April 3, 2008 Rib-X Pharmaceuticals,Inc. (...pany focused on the,discovery and development of n...esistant infections, today announced that Albert C...esenting at the 10th Annual,Superbugs & Superdrugs...
Other Medicine Technology:Thermo Fisher Scientific Receives FDA Clearance for MRSA Test Medium 2Thermo Fisher Scientific Receives FDA Clearance for MRSA Test Medium 3Thermo Fisher Scientific Receives FDA Clearance for MRSA Test Medium 4Rib-X Pharmaceuticals to Present at 10th Annual Superbugs & Superdrugs Conference 2
(Date:11/7/2009)... 7 Speaker Nancy Pelosi...this afternoon following a Democratic Whip meeting...Below are the Speaker,s opening remarks: ,, "T... occasion for us to receive the President of the U...story with our vote and making progress for the Am...
(Date:11/7/2009)...e that all youth will rebel, expert says , ...more likely to behave badly if their parents expec...who believe they are simply being realistic might ..." Christy Buchanan, a psychology professor at Wake...d in a university news release. "Negative expectat...
(Date:11/7/2009)... In the current economic climate, many Americans...only spending money on what that they consider to ...on David D. Kim believes that it’s very imp...eceive treatment to improve their health, and he i... patients in this tough economy by offering reason...
(Date:11/6/2009)...COM , VANCOUVER, Nov. 6 /PRNewswire-FirstCall/ - C...oday announced that it will report financial resul...on the morning of Monday, November 9, 2009. Cardio...9:00am Eastern (6:00am Pacific) on that day to dis..., please dial 416-695-7806 or 888-789-9572 and ref...
(Date:11/6/2009)... health bill loaded with pledge-breaking tax hikes...ed today by Americans for Tax Reform: ,, By form...President Barack Obama effectively announced that .... ,, During the campaign, Obama made a "firm pled...es making less than $250,000 per year: ,, "I can...
Breaking Medicine News(10 mins):Health News:Pelosi Remarks Following House Democrats' Meeting with President Obama 2Health News:Bad-Behaving Teens May Be Living Up to Expectations 2Health News:Dallas Bariatric Surgeon Offers Multiple Options for Patients Considering Weight Loss Surgery in a Rough Economy 2Health News:Dallas Bariatric Surgeon Offers Multiple Options for Patients Considering Weight Loss Surgery in a Rough Economy 3Health News:Cardiome to Release Third Quarter Results 2Health News:Cardiome to Release Third Quarter Results 3Health News:ATR: Obama Lied, His Tax Pledge Died 2Health News:ATR: Obama Lied, His Tax Pledge Died 3
...individuals may be wired differently , , T...itry that controls appetite might be wired differe...m to obesity, California researchers suggest. , Th...Obesity Research at the National Institute of Diab...
...finalised an agreement with an ESA-led consortium ...on, which contributes to the premature deaths of h...er the agreement, the European Environment Agency ...tion on air quality daily, to support the implemen...
...wing,release was issued today by the SCOOTER Store...ten-year resident at the,Eden Home long-term care ...perations, Dan Gibbens, The SCOOTER Store EVP of ...s deliver donation of power wheelchair,to local re...
...tCall/ - Bioniche Life Sciences,Inc. (TSX: BNC), a...rmaceutical company, today received notice from th...hat the latest data for its E. coli,O157:H7 cattle...uld collect sufficient data to move the product to...
...ement,by Daniel W. Jones, M.D., American Heart Ass...esident had an opportunity to leave his,mark in th...,s No. 1 killer,and costliest disease. Instead, hi...tum will be lost if research and,prevention progra...
...lty,Products Association (CSPA) is separating fact...lean with the launch of its new consumer website, ...urrounded by invisible germs that can have a signi...onsider,to achieve a truly clean home, such as cho...
Other Medicine News:Health News:Born to Be Obese? 2Health News:Born to Be Obese? 3Health News:Satellite data to deliver 'state-of-the-art' air quality information 2Health News:USDA Agrees to Grant Conditional License to Bioniche for its E. coli O157:H7 Cattle Vaccine 2Health News:USDA Agrees to Grant Conditional License to Bioniche for its E. coli O157:H7 Cattle Vaccine 3Health News:USDA Agrees to Grant Conditional License to Bioniche for its E. coli O157:H7 Cattle Vaccine 4Health News:Statement by Daniel W. Jones, M.D., American Heart Association President on President Bush's FY 2009 Budget Proposal 2Health News:Smart Home Cleaning: New Web Site Educates Consumers on Looking Clean Versus Being Clean 2
ABX Pentra DF 120
PDM PD Meter
Optima III 45 Noninsulated Stabilizing Grasper, without ratchet
Optima III 45 Noninsulated Cobra Grasper, without ratchet
Medicine Products: